Results 41 to 50 of about 14,264 (186)

Evidence review : liraglutide for the treatment of type 2 diabetes [PDF]

, 2011
This paper presents a summary of the evidence review group (ERG) report into the clinical effectiveness and cost-effectiveness of liraglutide in the treatment of type 2 diabetes mellitus, based upon the manufacturer’s submission to the National Institute
Cummins, E. (Ewen), Waugh, Norman, Shyangdan, D. (Deepson), Royle, Pamela, HASH(0x55a67fac50c0)   +4 more
core  

Insulin glargine use and breast cancer risk:Associations with cumulative exposure [PDF]

, 2016
Background: This study was aimed to assess the risk of breast cancer associated with exposure to insulin glargine in women with type 2 diabetes and evaluate whether the pattern of risk concurs with the hypothesized trend of an increase in risk with ...
Peeters, Paul J. H. L., Marie L. De Bruin (391653), van Staa, Tjeerd P.; id_orcid, Sub Pharmacoepidemiology, Hubert G. M. Leufkens (193774), Leufkens, Hubert G, Peeters, Paul J, van Staa, Tjeerd P., De Bruin, Marie L, Bazelier, Maroles T, Anssi Auvinen (24931), Pharmacoepidemiology and Clinical Pharmacology, Sub Gen. Pharmacoepi and Clinical Pharm, Marloes T. Bazelier (2697898), Peeters, Paul J H L, Auvinen, Anssi, Leufkens, Hubert G M, Sub Clinical Pharmacy, Pharmacoepi, Leufkens, Hubert G. M., Paul J. H. L. Peeters (2697895), de Vries, Frank; id_orcid, Tjeerd P. van Staa (193778), Bazelier, Marloes T, Frank de Vries (430757), De Bruin, Marie L., de Vries, Frank, van Staa, Tjeerd P, Bazelier, Marloes T.   +27 more
core   +2 more sources

A Difference Between Bedtime and Pre-Breakfast Plasma Glucose Levels Indicates the Need for Prandial Insulin in Basal Insulin-Treated Type 2 Diabetic Patients with Normal Fasting Glucose

Diabetes, Metabolic Syndrome and Obesity, 2021
Stephan Kress,1 Anja Borck,2 Ariel Zisman,3 Peter Bramlage,4,5 Thorsten Siegmund6 1Diabeteszentrum, Vinzentius-Krankenhaus, Landau, Germany; 2Medical Department, Sanofi, Berlin, Germany; 3The Endocrine Center of Aventura, Aventura, FL, USA; 4Institute ...
Kress S, Borck A, Zisman A, Bramlage P, Siegmund T   +4 more
doaj  

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

ESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou, Panagiotis Sardellis, Josip Plascevic, Ribeya Awaes‐Mahmood, Justyna Kaczmarek, Daniel Black Boada, Rosa Thuemmler, Sam Philip   +7 more
wiley   +1 more source

Forest plot: comparison of insulin glargine vs. non-glargine insulins and risk of prostate cancer.

, 2013
Forest plot: comparison of insulin glargine vs. non-glargine insulins and risk of prostate cancer.
Juan Zhou (207536), Yan-bo Chen (489289), Qi Chen (144168), Zhong Wang (132073)   +3 more
core   +1 more source

MYL1501D Insulin Glargine: A Review in Diabetes Mellitus

, 2020
Compliance with Ethical StandardsFunding: The preparation of this review was not supported by any external funding.Conflicts of interest: Sheridan Hoy is a salaried employee of Adis International Ltd/SpringerNature, is responsible for the article content
Sheridan M. Hoy (4897468)
core   +1 more source

Peripheral targets for neuropathic pain

British Journal of Pharmacology, EarlyView.
Neuropathic pain represents a significant clinical challenge, with still limited pharmacological approaches to symptomatic relief. This review focuses on molecular targets implicated in neuropathic pain, particularly those involved in peripheral mechanisms. Using the IUPHAR/BPS database of biological targets, their occurrence together with ‘neuropathic
Amirhossein Afsharipour, Cosmin I. Ciotu, Felix J. Resch, Michael J. M. Fischer   +3 more
wiley   +1 more source

Interventions for binge eating disorder in adults with type 2 diabetes: A systematic review

Diabetic Medicine, EarlyView.
Abstract Aims Binge eating disorder frequently co‐occurs with type 2 diabetes, creating a dual burden that may complicate both psychological well‐being and glycaemic management. Evidence on the effectiveness of health interventions in this population is limited.
Pernille Fiil Nybo, Nikolaj Vang Nielsen, Julie Drotner Mouritsen, Michael Einar Røder, Jakob Linnet   +4 more
wiley   +1 more source

Economic analysis of Lixisenatide in Diabetes Mellitus Type 2

Качественная клиническая практика, 2018
Usage of glucagon like peptide-1 receptors’ agonists (aGLP-1) is a new step in the treatment of Diabetes Mellitus Type 2 (DM 2). General attractive effects are positive effect on bodyweight, lower risk of hypoglycemia, compliance and possibility of ...
A. S. Kolbin, A. A. Mosikyan, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, W. Zhao   +5 more
doaj  

Insulin Toujeo® — a Novel Basal Long-Acting Insulin Formulation. Part 1. Pharmacokinetic and Pharmacodynamic Aspects

Mìžnarodnij Endokrinologìčnij Žurnal, 2015
This review, consisting of two parts, considers a new formulation of insulin glargine (rDNA origin) in the form of injections 300 U/ml (Gla-300, Toujeo®).
V.V. Poltorak, N.A. Kravchun, M.Yu. Gorshunska   +2 more
doaj   +1 more source